Sort
39,280 grants matching “leukemia”
Molecular Mechanisms in Gastrointestinal Stromal Tumor
$573,359Ronald P Dematteo · Sloan-Kettering Inst Can Research · R01 · FY2008 · CA
Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype
$573,343Derek L Stirewalt · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA
Role of T Regulatory Cells in Chronic Infection
$573,268Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Protein-coding and non-coding RNA biomarkers for early detection of CLL
$573,195George A. Calin · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · CA
Activation of Proto-Oncogenes by Chromosomal Translocation
$573,096Peter Aplan · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Center for Environment-Mediated Drug Resistance in Pediatric Cancer
$573,087Yves A Declerck · Children'S Hospital Of Los Angeles · U54 · FY2012 · CA
Role of an Aberrant N6-Methyladenosine-LncRNA Axis in the Development and Maintenance of Drug Resistance through Regulating the Leukemia Stem Cell
$573,003Shujun Liu · Case Western Reserve University · R01 · FY2024 · CA
CANCER AND LEUKEMIA GROUP B
$572,909Brigham And Women'S Hospital · U10 · FY2000 · CA
The role for phase separation in oncogenesis and aberrant chromatin looping formation
$572,770G Greg Wang · Duke University · R01 · FY2023 · CA
Predicting Relapse at the Time of Diagnosis in Acute Lymphoblastic Leukemia
$572,741Kara Lynn Davis · Stanford University · R01 · FY2023 · CA
Molecular Mechanisms in Gastrointestinal Stromal Tumor
$572,696Ronald P Dematteo · Sloan-Kettering Inst Can Research · R01 · FY2007 · CA
Genetic Predictors of AML Treatment Response
$572,691Richard Aplenc · Children'S Hosp Of Philadelphia · R01 · FY2011 · CA
NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN)
$572,671Elaine R Mardis · Washington University · U01 · FY2012 · GM
Defining the partner interaction network of the tetraspanin CD53 in regulating B cell trafficking
$572,610Laura G. Schuettpelz · Washington University · R01 · FY2022 · AI
OUTSTANDING INVESTIGATOR
$572,600University Of Minnesota Twin Cities · R35 · FY2000 · CA
MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM
$572,575Michael Schwartz · Mount Sinai Medical Center (Miami Beach) · U10 · FY2011 · CA
MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM
$572,572Michael Schwartz · Mount Sinai Medical Center (Miami Beach) · U10 · FY2012 · CA
Severe Chronic Neutropenia International Registry
$572,467David Chandler Dale · University Of Washington · R24 · FY2010 · AI
Targeting GSK3B in refractory B-cell malignancies
$572,454Markus Mãschen · Yale University · R01 · FY2024 · CA
RETROVIRUS EVOLUTION
$572,402Tufts University Boston · R01 · FY2002 · CA
Gene Regulation By Steroid Receptor Proteins
$572,358Keith Robert Yamamoto · University Of California, San Francisco · R01 · FY2013 · CA
Targeting Tumors with NF1 Loss
$572,285Yolanda Sanchez · Dartmouth College · R01 · FY2015 · NS
Primary screening and hit follow up to identify the first selective inhibitors of PLC?1 and PLC?2
$572,254Zhong-Yin Zhang · Purdue University · R01 · FY2025 · CA
Biomarkers for predicting response to Hsp90 therapy
$572,232Gabriela Chiosis · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Screening for Resistant Enteric Bacteria to Personalize Infection Prevention Strategies in Neutropenic Patients
$572,183Michael Joseph Satlin · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · AI